Your search for

2 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Legal news
    11 October 2018
    EU migration post-Brexit: recommendations of the Migration Advisory Committee
    www.twobirds.com/en/news/articles/2018/uk/eu-migration-post-brexit-recommendations-of-the-migration-advisory-committee

    In September 2018, employers and EU citizens welcomed the final report from the Migration Advisory Committee (MAC), which sketched the outline of a future migration landscape for EU workers.